logo

Regeneron Pharmaceuticals (REGN)



Trade REGN now with
  Date
  Headline
9/20/2019 7:00:41 AM The Lancet Publishes Results From 2 Positive Phase 3 Trials Of Dupixent In Chronic Rhinosinusitis With Nasal Polyps
9/20/2019 6:46:39 AM Regeneron: EMA's CHMP Adopts Positive Opinion For Dupixent In Third Indication
8/14/2019 7:01:23 AM Regeneron Announces Positive Topline Results From Phase 3 Trial Of Evinacumab
8/13/2019 7:02:30 AM Regeneron Pharma: FDA Approves EYLEA Injection Prefilled Syringe
8/12/2019 10:03:16 AM PALM Ebola Trial Stopped Early As Regeneron's REGN-EB3 Therapy Shows Superiority To ZMapp In Preventing Ebola Deaths
8/6/2019 6:31:38 AM Regeneron Q2 Revenues Increase 20% To $1.93 Bln
8/6/2019 2:17:41 AM Meggitt: Philip Green, Executive Director, Commercial & Corporate Affairs, To Retire From Board At The End Of Dec
6/28/2019 7:01:29 AM Regeneron, Sanofi: CHMP Recommends Approval Of Dupixent For Moderate-to-Severe Atopic Dermatitis In Adolescents
  
 
>